Clinical trial
Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome
NCT00006185 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00006185 |
|---|---|
| Title | Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome |
| Official title | Cellular Mechanisms for Metabolic Dysfunction in HIV |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, Lipodystrophy, Insulin Resistance |
| Intervention type | Drug |
| Interventions | Avandia administration for 6-12 weeks |
| Start date | Sep 1, 1999 |
| Completion | Aug 1, 2003 |
| First posted | Aug 23, 2000 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: